KRAS and pancreatic neoplasm: Acute KRAS silencing in KRAS‐mutant pancreatic cancer cells by RNAi or CRISPR caused cell cycle arrest, apoptosis, and reduction of anchorage‐independent proliferation in vitro, as well as reduced tumour growth and metastasis in xenograft models.